Dr. Sipkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2400 Pratt St.
Duke University
Durham, NC 27705Phone+1 919-668-1002- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2005
- Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
- Stanford University School of MedicineClass of 1999
Certifications & Licensure
- NC State Medical License 2014 - 2024
- IL State Medical License 2005 - 2014
- MA State Medical License 2002 - 2007
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsPan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.Sarah M. Ridge, Andrew E. Whiteley, Hisayuki Yao, Trevor T. Price, Maegan L. Brockman, Andrew S. Murray, Brennan G. Simon, Prioty Islam, Dorothy A. Sipkins> ;Leukemia & Lymphoma. 2021 Aug 6
- 52 citationsLeukaemia: a model metastatic diseaseAndrew E. Whiteley, Trevor T. Price, Gaia Cantelli, Dorothy A. Sipkins> ;Nature Reviews. Cancer. 2021 May 5
- 14 citationsSalting the Soil: Targeting the Microenvironment of Brain Metastases.Ethan S Srinivasan, Aaron Tan, Carey K. Anders, Ann Marie Pendergast, Dorothy A. Sipkins, David M. Ashley, Peter E. Fecci, Mustafa Khasraw> ;Molecular Cancer Therapeutics. 2021 Jan 5
- Join now to see all
Press Mentions
- GlycoMimetics to Share GMI-1359 and Galectin-3 Antagonist Program Data at AACR 2021 MeetingMarch 10th, 2021
- First Patient with Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359January 30th, 2020
- GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359November 13th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: